1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Linamar Corporation
  6. News
  7. Summary
    LNR   CA53278L1076

LINAMAR CORPORATION

(LNR)
  Report
Delayed Toronto Stock Exchange  -  04:15 2022-07-05 pm EDT
53.16 CAD   -3.50%
06/06Linamar Completes the Acquisition of the Salford Group
AQ
06/03Linamar Closes C$260-Milion Acquisition of Salford Group
MT
06/03Linamar Completes the Acquisition of the Salford Group
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Linamar Corporation Forms Linamar MedTech

05/19/2022 | 06:35pm EDT

Linamar Corporation announced the formation of Linamar MedTech, a new medical manufacturing group which will focus on leveraging its expert capabilities in precision manufacturing to pursue opportunities in the Medical Device and Precision Medical Component markets.  Linamar's quality management system has demonstrated it can meet the required industry standards for medical devices.  By utilizing the Linamar global operating structure and manufacturing footprint, Linamar plans to manufacture precision medical components and complex medical device assemblies for the global medical market.  Potential targeted products include surgical, respiratory, and imaging devices and precision components for devices, orthopedics, and prosthesis.


© S&P Capital IQ 2022
All news about LINAMAR CORPORATION
06/06Linamar Completes the Acquisition of the Salford Group
AQ
06/03Linamar Closes C$260-Milion Acquisition of Salford Group
MT
06/03Linamar Completes the Acquisition of the Salford Group
AQ
05/26Linamar Corporation Announces Voting Results from Annual General Meeting
AQ
05/26LINAMAR CORPORATION : Ex-dividend day for
FA
05/20RBC Capital Markets Says Supply Chain For Auto Supplies Improving
MT
05/20Linamar Creating Linamar MedTech, a New Group Focused on Medical Devices and Precision ..
MT
05/19Linamar Announces Creation of Linamar MedTech, a new group focused on Medical Devices a..
AQ
05/19Linamar Corporation Forms Linamar MedTech
CI
05/11TRANSCRIPT : Linamar Corporation, Q1 2022 Earnings Call, May 11, 2022
CI
More news
Analyst Recommendations on LINAMAR CORPORATION
More recommendations
Financials
Sales 2022 7 393 M 5 660 M 5 660 M
Net income 2022 - - -
Net Debt 2022 34,0 M 26,0 M 26,0 M
P/E ratio 2022 -
Yield 2022 1,50%
Capitalization 3 453 M 2 643 M 2 643 M
EV / Sales 2022 0,47x
EV / Sales 2023 0,40x
Nbr of Employees 26 000
Free-Float 68,6%
Chart LINAMAR CORPORATION
Duration : Period :
Linamar Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LINAMAR CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 53,16 CAD
Average target price 76,00 CAD
Spread / Average Target 43,0%
Managers and Directors
Linda S. Hasenfratz Executive Chairman & Chief Executive Officer
James Daniel Jarrell President, Chief Operating Officer & Director
Dale Schneider Financial Analyst
Mark Stoddart Non-Independent Director
Terry J. Reidel Independent Director
Sector and Competitors